DHI
DR Horton Inc
DR Horton Inc historical holders
total: 14
Fairholme Capital Management DR Horton Inc transactions over time
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2022 Q2
- Held for:
- 1 quarter
- Latest activity:
- 2022 Q3
Bruce Berkowitz has been an institutional investor in DR Horton Inc (DHI) since 2022 Q2. According to 2026 Q2 report, Bruce Berkowitz doesn't hold any shares. The fund/company first acquired DHI in 2022 Q2, initially purchasing 71,000 shares. Since the initial investment, Fairholme Capital Management has made 1 more transaction in this position.
When did Bruce Berkowitz exit their DHI position?
Bruce Berkowitz no longer holds DR Horton Inc (DHI). They sold off their entire position in 2022 Q3, closing out an investment that began in 2022 Q2.
When did Bruce Berkowitz first invest in DHI?
Bruce Berkowitz first invested in DR Horton Inc (DHI) in 2022 Q2 at the reported quarter-end price of $66.18 per share, acquiring 71,000 shares in their initial purchase.
What is Bruce Berkowitz's average cost basis for DHI?
Based on historical transaction data, Bruce Berkowitz's estimated cost basis for DR Horton Inc (DHI) is approximately $66.18 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $66.18
- Weighted AVG sell price:
- $66.18
DHI transactions history by Fairholme Capital Management
2 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2022 Q3
|
0.00%
|
0
|
$66.18
|
|
-100% (-71,000)
|
-0.39%
|
|
2022 Q2
|
0.39%
|
71,000
|
$66.18
|
$4,699,000
|
new
|
+0.39%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.